Katharine Yao to Time-to-Treatment
This is a "connection" page, showing publications Katharine Yao has written about Time-to-Treatment.
Connection Strength
4.790
-
Impact of Quality Improvement Interventions on Biopsy-to-Treatment Time in Breast Cancer: Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers. Ann Surg Oncol. 2025 Oct; 32(11):8256-8268.
Score: 0.811
-
Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data. Ann Surg Oncol. 2025 Mar; 32(3):2045-2055.
Score: 0.775
-
Time From Screening to Treatment at Accredited Breast Centers in the United States. JCO Oncol Pract. 2025 Jun; 21(6):781-790.
Score: 0.774
-
Patient-reported observations on medical procedure timeliness (PROMPT) in breast cancer: a qualitative study. Breast Cancer Res Treat. 2024 Nov; 208(1):123-132.
Score: 0.752
-
Covid-19 related oncologist's concerns about breast cancer treatment delays and physician well-being (the CROWN study). Breast Cancer Res Treat. 2021 Apr; 186(3):625-635.
Score: 0.593
-
Treatment delays from transfers of care and their impact on breast cancer quality measures. Breast Cancer Res Treat. 2019 Feb; 173(3):603-617.
Score: 0.509
-
Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015 Mar; 22(3):899-907.
Score: 0.381
-
Did the COVID-19 consortium recommendations impact the treatment of breast cancer during the COVID-19 pandemic? Breast Cancer Res Treat. 2025 May; 211(1):11-22.
Score: 0.195